688131 皓元医药
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)2.1387.9757.4845.2789.350
总资产报酬率 ROA (%)1.0614.0654.1583.2726.474
投入资产回报率 ROIC (%)1.2034.6074.7083.7857.555

边际利润分析
销售毛利率 (%)52.42547.10447.96545.16851.444
营业利润率 (%)10.18210.31510.4326.82614.474
息税前利润/营业总收入 (%)13.95211.77712.0208.51314.577
净利润/营业总收入 (%)8.6478.0528.7196.71814.105

收益指标分析
经营活动净收益/利润总额(%)150.506157.529154.935161.741107.449
价值变动净收益/利润总额(%)-0.343-5.763-5.709-3.7238.085
营业外收支净额/利润总额(%)-0.062-7.6070.645-0.1060.995

偿债能力分析
流动比率 (X)2.1582.1312.5191.8802.217
速动比率 (X)1.3441.3401.5970.8961.109
资产负债率 (%)49.95149.38747.24339.73935.183
带息债务/全部投入资本 (%)38.20836.62233.21224.23215.367
股东权益/带息债务 (%)145.729155.175177.147282.011492.789
股东权益/负债合计 (%)99.002100.885110.658150.611183.280
利息保障倍数 (X)3.6945.3757.9065.025-342.766

营运能力分析
应收账款周转天数 (天)82.19173.08777.06175.32063.743
存货周转天数 (天)378.999303.811351.690359.057344.748